Author:
Seok Su Hyun,Kim Ju-Young,Park Chun-Woong,Rhee Yun-Seok,Park Eun-Seok
Funder
National Research Foundation of Korea
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. The United States Pharmacopeia (USP). <696> Characterization of crystalline solids by microcalorimetry and solution calorimetry monograph. In: The United States Pharmacopeia and The National Formulary: The Official Compendia of Standards. USP38-NF33. Rockville, MD: The United States Pharmacopeial Convention Inc.; 2015. pp. 474–7.
2. Hancock BC, Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci. 1997;86(1):1–12. https://doi.org/10.1021/js9601896.
3. Shalaev E, Wu K, Shamblin S, Krzyzaniak JF, Descamps M. Crystalline mesophases: structure, mobility, and pharmaceutical properties. Adv Drug Deliv Rev. 2016;100:194–211. https://doi.org/10.1016/j.addr.2016.04.002.
4. Thakral S, Terban MW, Thakral NK, Suryanarayanan R. Recent advances in the characterization of amorphous pharmaceuticals by x-ray diffractometry. Adv Drug Deliv Rev. 2016;100:183–93. https://doi.org/10.1016/j.addr.2015.12.013.
5. Babu NJ, Nangia A. Solubility advantage of amorphous drugs and pharmaceutical cocrystals. Cryst Growth Des. 2011;11(7):2662–79. https://doi.org/10.1021/cg200492w.